Streetbeat News

Analyst Ratings

CLBK

Piper Sandler analyst Mark Fitzgibbon has maintained a Neutral rating on Columbia Financial (NASDAQ:CLBK) and increased the price target from $19 to $20.

Portfolio Pulse from Benzinga Newsdesk

January 26, 2024 | 6:34 pm

ASB

Piper Sandler analyst Scott Siefers has maintained a Neutral rating on Associated Banc-Corp (NYSE:ASB) and increased the price target from $21.5 to $23.

Portfolio Pulse from Benzinga Newsdesk

January 26, 2024 | 6:31 pm

AAL

American Airlines Group Inc (NASDAQ:AAL) exceeded Q4 2023 earnings expectations with a 75% drop in adjusted earnings to $0.29 per share, surpassing the $0.10 consensus. Revenue fell 1% to $13.06 billion, slightly above the $13.02 billion estimate. The company forecasts a Q1 2024 adjusted loss per share of ($0.15)-($0.35), compared to the consensus of $(0.17), and full-year 2024 earnings of $2.25-$3.25 per share, in line with expectations. Capacity is expected to increase 6.5%-8.5% Y/Y in Q1 and mid-single digits for the full year. Following the report, AAL shares dropped 1.1%. Analysts from TD Cowen, JP Morgan, Barclays, and Seaport Global adjusted their price targets and ratings, with upgrades from TD Cowen and Seaport Global.

Portfolio Pulse from Avi Kapoor

January 26, 2024 | 6:30 pm

ARGX

Piper Sandler analyst Allison Bratzel has maintained an Overweight rating on argenx (NASDAQ:ARGX) and increased the price target from $518 to $522.

Portfolio Pulse from Benzinga Newsdesk

January 26, 2024 | 6:29 pm

AAL

Barclays analyst Brandon Oglenski has maintained an Underweight rating on American Airlines Group (NASDAQ:AAL) but increased the price target from $13 to $14.

Portfolio Pulse from Benzinga Newsdesk

January 26, 2024 | 6:24 pm

ABT

Barclays analyst Matt Miksic has maintained an Overweight rating on Abbott Laboratories (NYSE:ABT) and increased the price target from $133 to $141, indicating a positive outlook on the company's stock.

Portfolio Pulse from Benzinga Newsdesk

January 26, 2024 | 6:22 pm

TSLA

Wedbush analyst Daniel Ives lowered Tesla's price target from $350 to $315 and removed it from the Best Ideas List after a disappointing Q4 report and vague 2024 guidance. Ives criticized Tesla's earnings call and suggested a 10-point plan to improve share performance, including a $10 billion buyback, a new 'X Holding' structure for AI initiatives, maintaining automotive margins, hosting an AI Day, securing outside capital for X/Twitter, a new CEO compensation package, setting a Model 2 production timeline, returning to formal guidance, AI acquisitions, and setting long-term AI targets.

Portfolio Pulse from Chris Katje

January 26, 2024 | 6:15 pm

APPF

Stephens & Co. analyst John Campbell has reiterated an Overweight rating on AppFolio (NASDAQ:APPF) and maintained a price target of $241.

Portfolio Pulse from Benzinga Newsdesk

January 26, 2024 | 6:12 pm

HUM

Stephens & Co. analyst Scott Fidel has maintained an Overweight rating on Humana (NYSE:HUM) but reduced the price target from $550 to $430.

Portfolio Pulse from Benzinga Newsdesk

January 26, 2024 | 6:09 pm

GM

HTGC

JEPI

TOST

On CNBC's Halftime Report, analysts shared their final trades, which included Toast Inc. (TOST), JPMorgan Equity Premium Income ETF (JEPI), Hercules Capital (HTGC), and General Motors (GM). These recommendations provide insights into the analysts' views on these assets.

Portfolio Pulse from Benzinga Newsdesk

January 26, 2024 | 6:07 pm